Control of disease can be achieved w Ibrutnib   High-risk Relapsed Refractory patients will progress

Control of disease can be achieved w Ibrutnib High-risk Relapsed Refractory patients will progress

hematologydebates

1 year
46 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jose F. Leis, MD, PhD, explains how Control of disease can be achieved with Ibrutnib High-risk Relapsed Refractory patients will progress at Imedex Great Debates 2018.
Up Next Autoplay